Outcomes With Finerenone by Baseline Treatment Goals in Type 2 Diabetes and Chronic Kidney Disease: A FIDELITY Analysis.

Neves JS, Leite AR, Vasques-Nóvoa F, Pitt B, Filippatos G, Ruilope LM, Rossing P, Anker SD, Savarese G, Scott CAB, Lage A, Brinker MD, Ferreira JP

Open source

DOI: 10.1111/dom.70750
Published: 2026 Jul
Container: Diabetes, obesity & metabolism
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1111/dom.70750,
  title = {Outcomes With Finerenone by Baseline Treatment Goals in Type 2 Diabetes and Chronic Kidney Disease: A FIDELITY Analysis.},
  author = {Neves JS and Leite AR and Vasques-Nóvoa F and Pitt B and Filippatos G and Ruilope LM and Rossing P and Anker SD and Savarese G and Scott CAB and Lage A and Brinker MD and Ferreira JP},
  year = {2026},
  journal = {Diabetes, obesity \& metabolism},
  doi = {10.1111/dom.70750},
  url = {https://doi.org/10.1111/dom.70750}
}

RIS

TY  - JOUR
TI  - Outcomes With Finerenone by Baseline Treatment Goals in Type 2 Diabetes and Chronic Kidney Disease: A FIDELITY Analysis.
AU  - Neves JS
AU  - Leite AR
AU  - Vasques-Nóvoa F
AU  - Pitt B
AU  - Filippatos G
AU  - Ruilope LM
AU  - Rossing P
AU  - Anker SD
AU  - Savarese G
AU  - Scott CAB
AU  - Lage A
AU  - Brinker MD
AU  - Ferreira JP
PY  - 2026
JO  - Diabetes, obesity & metabolism
DO  - 10.1111/dom.70750
UR  - https://doi.org/10.1111/dom.70750
ER  -

APA

JS, N., AR, L., F, V., B, P., G, F., LM, R., P, R., SD, A., G, S., CAB, S., A, L., MD, B., & JP, F. (2026). Outcomes With Finerenone by Baseline Treatment Goals in Type 2 Diabetes and Chronic Kidney Disease: A FIDELITY Analysis.. Diabetes, obesity & metabolism. https://doi.org/10.1111/dom.70750

Source records

pubmed · retrieved 2026-09-25T16:22:22.025Z